Wave Life Sciences(WVE)
$3.16-0.27 (-7.75%)
WVE
Wave Life Sciences stock forecast
$3.16
At close:-0.27 (-7.75%)
Want to see WVE full AI Analyst Report?
Wave Life Sciences (WVE) Stock Forecast & Price Target
1,469 Followers
WVE Analyst Ratings
Strong Buy
14Buy1Hold0Sell
Based on 15 analysts giving stock ratings to Wave Life Sciences in the past 3 months
WVE Stock 12 Month Forecast
Average Price Target
$16.57▲(425.10% Upside)Based on 15 Wall Street analysts offering 12 month price targets for Wave Life Sciences in the last 3 months. The average price target is $16.57 with a high forecast of $44.00 and a low forecast of $8.37. The average price target represents a 425.10% change from the last price of $3.15.
Past 12 Months12 Month ForecastJan2026Oct2026
High$44.00
Average$16.57
Low$8.37
Highest Price TargetHighest$44.00Average Price Target$16.57Lowest Price TargetLowest$8.37
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Samantha Semenkow | Citi | $19→$15 | buy | 375.44%Upside | Reiterated | 11/12/26 | ||
| Ananda Ghosh | H.C. Wainwright | $13 | buy | 312.04%Upside | Reiterated | 11/10/26 | ||
| Madison Elsaadi | B. Riley Securities | $22→$18 | buy | 470.52%Upside | Reiterated | 11/09/26 | ||
| Alec Stranahan | Bank of America Securities | $17→$16 | buy | 407.13%Upside | Reiterated | 11/04/26 | ||
| Yun Zhong | Wedbush | $12 | buy | 280.35%Upside | Reiterated | 11/04/26 | ||
| Whitney Ijem | Canaccord Genuity | $44 | buy | 1294.61%Upside | Reiterated | 11/04/26 | ||
| Joseph Schwartz | Leerink Partners | $12→$10 | buy | 216.96%Upside | Assigned | 10/29/26 | ||
| Joon Lee | UBS | $11 | buy | 248.65%Upside | Assigned | 10/28/26 | ||
| Benjamin Burnett | Wells Fargo | $14 | buy | 343.74%Upside | Reiterated | 10/28/26 | ||
| Cheng Li | Oppenheimer | $32→$29 | buy | 819.18%Upside | Reiterated | 10/28/26 | ||
| Luca Issi | RBC Capital | $15 | buy | 375.44%Upside | Reiterated | 10/27/26 | ||
| Alethia Young | William Blair | $8.37 | buy | 165.29%Upside | Initiated | 10/15/26 | ||
| Danielle Brill | Truist Financial | ― | buy | ― | Reiterated | 10/02/26 | ||
| Rick Bienkowski | Ladenburg Thalmann & Co. | $10 | buy | 216.96%Upside | Initiated | 10/01/26 | ||
| Tessa Romero | J.P. Morgan | ― | hold | ― | Downgraded | 09/23/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Samantha SemenkowCiti | BuyReiterated$19→$15 | 11/12/26 | 375.44%Upside | ||
| Ananda GhoshH.C. Wainwright | BuyReiterated$13 | 11/10/26 | 312.04%Upside | ||
| Madison ElsaadiB. Riley Securities | BuyReiterated$22→$18 | 11/09/26 | 470.52%Upside | ||
| Alec StranahanBank of America Securities | BuyReiterated$17→$16 | 11/04/26 | 407.13%Upside | ||
| Yun ZhongWedbush | BuyReiterated$12 | 11/04/26 | 280.35%Upside | ||
| Whitney IjemCanaccord Genuity | BuyReiterated$44 | 11/04/26 | 1294.61%Upside | ||
| Joseph SchwartzLeerink Partners | BuyAssigned$12→$10 | 10/29/26 | 216.96%Upside | ||
| Joon LeeUBS | BuyAssigned$11 | 10/28/26 | 248.65%Upside | ||
| Benjamin BurnettWells Fargo | BuyReiterated$14 | 10/28/26 | 343.74%Upside | ||
| Cheng LiOppenheimer | BuyReiterated$32→$29 | 10/28/26 | 819.18%Upside | ||
| Luca IssiRBC Capital | BuyReiterated$15 | 10/27/26 | 375.44%Upside | ||
| Alethia YoungWilliam Blair | BuyInitiated$8.37 | 10/15/26 | 165.29%Upside | ||
| Danielle BrillTruist Financial | BuyReiterated | 10/02/26 | ― | ||
| Rick BienkowskiLadenburg Thalmann & Co. | BuyInitiated$10 | 10/01/26 | 216.96%Upside | ||
| Tessa RomeroJ.P. Morgan | HoldDowngraded | 09/23/26 | ― |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Wave Life Sciences
3 Months
Success Rate9/21 ratings generated profit
43%
Average Return
+13.29%
Copying Joseph Schwartz's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +13.29% per trade.
1 Year
Success Rate12/21 ratings generated profit
57%
Average Return
+17.33%
Copying Joseph Schwartz's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +17.33% per trade.
2 Years
Success Rate20/44 ratings generated profit
45%
Average Return
+18.70%
Copying Salim Syed's trades and holding each position for 2 Years would result in 45.45% of your transactions generating a profit, with an average return of +18.70% per trade.
WVE Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 19 | 14 | 16 | 25 | 27 |
| Buy | 1 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 20 | 14 | 17 | 27 | 29 |
In the current month, WVE has received 28 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. WVE average Analyst price target in the past 3 months is 16.57.
WVE Financial Forecast
High$-0.28
Consensus$-0.32
Low$-0.39
WVE Earnings Forecast
Next quarter’s earnings estimate for WVE is -$0.32 with a range of -$0.39 to -$0.28. The previous quarter’s EPS was -$0.30. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High$24M
Consensus$10.4M
Low$0.00
WVE Sales Forecast
Next quarter’s sales forecast for WVE is $10.43M with a range of $0 to $24.00M. The previous quarter’s sales results were $13.16M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
WVE Stock Forecast FAQ
What is WVE’s average 12-month price target, according to analysts?
Based on analyst ratings, Wave Life Sciences’s 12-month average price target is $16.57.
What is WVE’s upside potential, based on the analysts’ average price target?
Wave Life Sciences has 425.10% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is WVE a Buy, Sell or Hold?
Wave Life Sciences has a consensus rating of Strong Buy which is based on 14 buy ratings, 1 hold ratings and 0 sell ratings.
What is Wave Life Sciences’s price target?
The average price target for Wave Life Sciences is $16.57. This is based on 15 12-month price targets, issued in the past 3 months. The highest analyst price target is $44.00, the lowest forecast is $8.37. The average price target represents a 425.10% increase from the current price of $3.155.
What do analysts say about Wave Life Sciences?
Wave Life Sciences’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Street analysts.
How can I buy shares of WVE?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
